Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma.

Chung-Han LeeRobert J MotzerHilary GlenM D MichaelsonJames LarkinYukinori MinoshimaMichio KanekiyoHiroki IkezawaPallavi SachdevCorina E DutcusYasuhiro FunahashiMartin H Voss

Published in: British journal of cancer (2020)

The clinical trial registration number is NCT01136733.

Keyphrases

metastatic renal cell carcinoma
clinical trial
phase ii
open label
double blind
study protocol
electron microscopy
phase iii